Voting for the Outstanding Contribution to Cancer Control Awards 2023

The Cancer Institute NSW's eviQ program deserves recognition for its leadership in the field of cancer care. This state-wide government agency has made significant contributions to cancer care by providing freely accessible online cancer treatment protocols. These evidence-based guidelines have a global impact, with a diverse user base, including international healthcare professionals. EviQ's commitment to equity is evident through translation efforts, collaborations, and support for disadvantaged communities.

Liga contra el cancer in Peru has made a significant impact on cancer prevention, particularly among those with limited economic resources. They pioneered the "Population Screening" model through Mobile Units and Community Agent Networks. Their strong communication strategy has made them a national benchmark in cancer prevention. They've vaccinated schoolchildren, served millions of women, and conducted successful screening campaigns. Their commitment to equity is evident in providing free care, breaking socio-cultural barriers, and reaching vulnerable areas.

For over four decades, World Cancer Research Fund International (WCRFI) has pioneered research linking nutrition and cancer, producing influential reports and recommendations. Their efforts transcend borders, influencing national policies and reducing cancer risks. WCRFI prioritises equity by addressing health disparities and providing resources to disadvantaged communities. Their global recognition, official relations with WHO, and involvement in impactful initiatives solidify their leadership in cancer prevention research and advocacy.

Dr Freddie Bray is a leading figure at the International Agency for Research on Cancer (IARC), responsible for the Cancer Surveillance Section. He also leads the Global Initiative for Cancer Registration, an international multi-partner programme designed to ensure a sustainable expansion of the coverage and quality of population-based cancer registries in low- and middle- income countries. Dr Bray's unwavering commitment to data-driven policy saves lives and narrows cancer inequities at a large scale.

Dr Brenda Gallie is an internationally renowned ocular oncologist and the Head of the Retinoblastoma Program in the Hospital for Sick Children (Toronto). Her dedication to improving outcomes for children with retinoblastoma has transformed the field. She is known for her groundbreaking research, advocacy, innovative tools and compassionate care. Dr Gallie's commitment to equity is evident through her global efforts, bridging gaps in care and advocating for early detection, affordable treatment, and patient-centered research.

Dr David Poplack is a recognised leader in the field of pediatric oncology and served as Director of Texas Children’s Cancer Center for 25 years. Under his direction, the Center grew exponentially in faculty and impact. Dr Poplack is also the editor of a reference textbook in the field of pediatric oncology. His Global HOPE initiative with treatment and training centers in several African countries addresses alarming inequities and achieves significant improvements of survival rates.